Table 1.
Demographics
| Parameter | iNO group, n = 14 | Placebo group, n = 14 | p |
|---|---|---|---|
| BW (g) | 1047 ± 322 | 1018 ± 322 | 0.91 |
| GA (weeks)a | 28.6 (27, 29.9) | 28.1 (26.7, 29.1) | 0.29 |
| Apgar at 1 mina | 4 (2, 5) | 5 (4, 7) | 0.19 |
| Apgar at 5 mina | 7 (6, 8) | 8 (7, 8) | 0.50 |
| Race | 0.78 | ||
| Caucasian | 10 | 10 | |
| Black | 1 | 1 | |
| Native American | 2 | 1 | |
| Hispanic | 0 | 2 | |
| Others | 1 | 0 | |
| Males | 11 | 7 | 0.24 |
| Antenatal steroid (any) | 10/14 (71%) | 11/14 (79%) | 0.66 |
| Antenatal steroid (complete course) | 9/14 (64%) | 8/14 (57%) | 0.70 |
| Chorioamnionitis | 3/14 (21%) | 2/14 (14%) | 0.62 |
| ROM (>18 h) | 4/14 (29%) | 2/14 (14%) | 0.36 |
| Preeclampsia | 5/14 (36%) | 4/14 (29%) | 0.69 |
ROM rupture of membrane
aMedian (interquartile range)